From: Elevated serum levels of checkpoint molecules in patients with adult Still’s disease
Characteristics | Value |
---|---|
Number, n | 47 |
Age (years), median (IQR) | 40 (28–56) |
Age at onset (years), median (IQR) | 39 (27–56) |
Male, n (%) | 15 (31.9) |
WBC (μL), median (IQR) | 9900 (7700–16,150) |
Ferritin (ng/mL), median (IQR) | 1159 (310–3887) |
CRP (mg/dL), median (IQR) | 6.8 (2.9–10.9) |
ALT (IU/L), median (IQR) | 33 (20–68) |
Pouchot’s score, median (IQR) | 3 (2–5) |
PSL (mg/day), median (IQR) | 40 (40–60) |
Corticosteroid pulse therapy, n (%) | 24 (54.5) |
Immunosuppressant, n (%) | 33 (75.0) |
Biologics, n (%) | 6 (15.6) |
Polycyclic systemic type, n (%) | 29 (64.4) |
Monocyclic systemic type, n (%) | 15 (33.3) |
Chronic arthritis type, n (%) | 6 (15.6) |